Piramal Pharma has completed the acquisition of 1,46,400 equity shares of Rs 10 each of Yapan Bio (an associate company) from its existing shareholders for an aggregate cash consideration of approximately Rs 76 crore. Pursuant to the acquisition, the Company's shareholding in Yapan has increased from 33.33% to 74.00% of the equity share capital of Yapan.